文献速递乳腺MR

Kaiser评分在新诊断乳腺癌患者中的诊断效能:与假阴性结果相关的因素

Diagnostic performance of Kaiser score in patients with newly diagnosed breast cancer: Factors associated with false-negative results.
PubMed 文献 · Eur J Radiol · 2023-05-12

该单中心回顾性研究纳入205例女性219个经病理证实的乳腺癌病灶,术前乳腺MRI按Kaiser评分评估,200个(91.3%)为真阳性、19个(8.7%)为假阴性;观察者间ICC为0.804(95%CI 0.751-0.846);多因素回归显示病灶小(≤1 cm,校正OR 6.86,95%CI 2.14-21.94,p=0.001)和既往乳腺癌病史(校正OR 7.59,95%CI 1.55-37.23,p=0.012)与假阴性Kaiser评分结果显著相关。

要点

  • Kaiser评分诊断乳腺癌的假阴性率为8.7%(19/219)。
  • 病灶≤1 cm与假阴性Kaiser评分结果显著相关(校正OR 6.86)。
  • 既往乳腺癌病史与假阴性Kaiser评分结果显著相关(校正OR 7.59)。

核心结论

  • 病灶小(≤1 cm)和既往乳腺癌病史是与Kaiser评分假阴性结果显著相关的因素。

研究设计与样本

  • 经机构审查委员会(IRB)批准的单中心回顾性研究,纳入205例女性219个连续经组织病理学证实的乳腺癌病灶,术前行乳腺MRI,由两名乳腺放射科医生按Kaiser评分评估,采用组内相关系数(ICC)评估观察者间一致性,多因素回归分析假阴性相关因素。

诊断标准与关键数值

  • Kaiser评分诊断乳腺癌:真阳性200个(91.3%),假阴性19个(8.7%);两名阅片者间Kaiser评分的ICC为0.804(95%CI 0.751-0.846);病灶≤1 cm的校正OR为6.86(95%CI 2.14-21.94,p=0.001);既往乳腺癌病史的校正OR为7.59(95%CI 1.55-37.23,p=0.012)。

临床应用与阅片要点

  • 作者认为放射科医生在临床实践中应考虑这些因素作为Kaiser评分的潜在陷阱,可能通过结合临床评估的多模态方法加以弥补。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the factors associated with false-negative results in the diagnosis of breast cancer via breast magnetic resonance imaging (MRI) using the Kaiser score (KS).

METHODS: This institutional review board (IRB)-approved, single-center, retrospective study enrolled 219 consecutive histopathologically proven breast cancer lesions in 205 women who underwent preoperative breast MRI. Two breast radiologists evaluated each lesion according to the KS. The clinicopathological characteristics and imaging findings were also analyzed. Interobserver variability was assessed using the intraclass correlation coefficient (ICC). Multivariate regression analysis was used to investigate factors associated with false-negative KS results for breast cancer diagnosis.

RESULTS: Of 219 breast cancers, KS yielded 200 (91.3%) true-positive and 19 (8.7%) false-negative results. The interobserver ICC for the KS between the two readers was good, with a value of 0.804 (95% CI 0.751-0.846). Multivariate regression analysis revealed that small lesion size (≤1 cm) (adjusted OR 6.86, 95% CI 2.14-21.94, p = 0.001) and personal breast cancer history (adjusted OR 7.59, 95% CI, 1.55-37.23, p = 0.012) were significantly associated with false-negative KS results.

CONCLUSION: Small lesion size (≤1 cm) and presence of personal breast cancer history are factors significantly associated with false-negative KS results. Our results suggest that radiologists should consider these factors in clinical practice as potential pitfalls of KS, which may be compensated for by a multimodal approach combined with clinical evaluation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Avdan Aslan, Gültekin. Diagnostic performance of Kaiser score in patients with newly diagnosed breast cancer: Factors associated with false-negative results. Eur J Radiol. 2023. PMID: 37209464. doi:10.1016/j.ejrad.2023.110864

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。